Meningioma research
Almost a quarter of all primary brain tumours in adults are meningiomas. As many as 90% are low grade meningiomas (Grades 1 and 2) but there is a small subset that are more aggressive (Grade 3).
Meningiomas develop in the membrane that cover and protect the brain and spinal cord. Current treatments depend on the size, location and nature of the tumour, but there are no targeted treatments, yet.
Current meningioma research projects
Here are the research projects we are currently funding that relate to understanding or treating meningioma.
Dr Gelareh Zadeh
Targeting meningioma through immune interactions
Dr Gelareh Zadeh
Targeting meningioma through immune interactions
Dr Gelareh Zadeh is exploring how four subgroups of meningioma respond to different types of radiotherapy. She will look at how tumour cells and immune cells interact with each other, to understand why there are differences between meningioma subgroups in the way they react to radiotherapy. Dr Zadeh will also be using AI to help sort meningiomas into their subgroups.
See Dr Zadeh’s project
Dr Gelareh Zadeh
Targeting clinically challenging meningiomas
Dr Gelareh Zadeh
Targeting clinically challenging meningiomas
Dr Zadeh and the team are investigating what make clinically aggressive meningiomas (CAMs) and radiation induced meningiomas (RIMs) different, and hard to treat. Find out more
Dr Gelareh Zadeh
Liquid biomarkers to change meningioma treatment
Dr Gelareh Zadeh
Liquid biomarkers to change meningioma treatment
This project is advancing research into how aggressive meningiomas can be diagnosed and how their treatment responses can be predicted. In collaboration with a major UK-led clinical trial and using advanced artificial intelligence, the team are striving towards tomorrow’s clinical care. Find out moreOther current research projects
Here are the research projects we are currently funding that relate to understanding or treatment of brain tumours including meningiomas.
Dr Jan Schuemann
Extreme dose rate proton therapy
